image
Healthcare - Biotechnology - NASDAQ - AU
$ 1.68
-9.52 %
$ 9.62 M
Market Cap
-2.04
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
212.23%
EBIT Estimate
--163.89%
Net Income Estimate
98.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Immuron Limited
image
IMRN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart IMRN

image
$16.0m$16.0m$14.0m$14.0m$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020152015201620162017201720182018201920192020202020232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart IMRN

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)20152015201620162017201720182018201920192020202020232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart IMRN

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)($1.6b)($1.6b)20152015201620162017201720182018201920192020202020232023202420242025202520262026